Skip to Content

Tag: Ectosense

Jim Hollingshead


ResMed buys HST company

October 4, 2021HME News Staff

SAN DIEGO – ResMed has bought Ectosense, which makes the NightOwl home sleep test.  The NightOwl, approved by the U.S. Food and Drug Administration, is currently sold in the United States, Australia, New Zealand, India and parts of Europe. ResMed has distributed the NightOwl, under the brand ResMed onesleeptest, in Australia, New Zealand and India since 2020, and has been a minority investor in Ectosense since July 2020.  "Sleep labs and home tests each have critical roles to...

CPAP Therapy, Ectosense, Home Sleep Testing, NightOwl, Obstructive Sleep Apnea (OSA), ResMed

Read Full Articlered right arrow icon